Home > Cardiology > New tool predicts mortality after percutaneous mitral-valve repair

New tool predicts mortality after percutaneous mitral-valve repair


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Journal
Journal of the American College of Cardiology
Reuters Health - 17/02/2022 - The eight-item MitraScore tool may help doctors decide which of their patients with severe mitral regurgitation will benefit from transcatheter edge-to-edge mitral-valve repair (TEER), researchers report. TEER with MitraClip (Abbott Vascular) is an alternative to surgery that has become the first-line intervention for secondary mitral regurgitation in high-risk patients, and second-line therapy for primary mitral regurgitation in high-risk patients, the team notes in the Journal of the American College of Cardiology. "The simple MitraScore, based on 8 clinical risk factors, can reasonably predict long-term mortality after mitral-valve TEER," Dr. Mohamad Alkhouli of Mayo Clinic Alix School of Medicine in Rochester, Minnesota, told Reuters Health by email. "This is the first purpose-specific risk-prediction scheme for mitral-valve TEER. It highlights the need for judicious use of the procedure and careful consideration of its utility and ...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on